ArticleJournal of molecular medicine (Berlin, Germany)2022

EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma.

Kui Su et al.PubMed ↗Publisher ↗

No numbers read from the abstract.